Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-948-9 | CAS number: 13560-89-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: only few animals were used
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
Materials and methods
- Objective of study:
- absorption
- distribution
- excretion
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Dechlorane Plus was administered once orally to few rats at two dose levels. Excretion via urine, faeces, and expired air and residual concentrations in organs and carcass were determined.
- GLP compliance:
- no
Test material
- Reference substance name:
- 1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
- EC Number:
- 236-948-9
- EC Name:
- 1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
- Cas Number:
- 13560-89-9
- Molecular formula:
- C18H12Cl12
- IUPAC Name:
- 1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro-1,4:7,10-dimethanodibenzo[a,e][8]annulene
- Test material form:
- not specified
- Details on test material:
- Radiolabeled Dechlorane Plus was synthetized from 14C-hexachlorocyclopentadiene and 1,4-cyclooctadiene and purified after TLC separation with hexane by LC purification in tetrahydrofuran. The ratio of isomers was 5.4 : 1.
(14C) Dechlorane Plus: purity: 99,2%
Constituent 1
- Radiolabelling:
- yes
- Remarks:
- 31.5 mCi/mmol 14C
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- The rats were maintained in all-glass metabolism cages with separate collection of urine and faeces.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- Single oral administration by gavage in corn oil, one group was fed non-labelled Dechlorane Plus at 1% in the diet for 14 days before gavage administration.
- Duration and frequency of treatment / exposure:
- Single administration, one group was fed non-labelled Dechlorane Plus at 1% in the diet for 14 days before gavage administration.
Doses / concentrations
- Dose / conc.:
- 1 mg/kg bw/day
- Remarks:
- Doses / Concentrations:
1 mg/kg bw corresponding to 4.8 µCi or 113 mg/kg bw corresponding to 3.8 µCi
- No. of animals per sex per dose / concentration:
- 3 females and 2 males at 1 mg/kg bw, 2 females at 113 mg/kg bw, 2 females at 1 mg/kg bw with prior administration in diet.
- Control animals:
- no
- Details on study design:
- One rat was used for monitoring radioactivity in exspired air, one rat was used for monitoring the time course of blood levels for 48 hours after administration of 1 mg/kg bw, of all remaining rats, urine and faeces were collected for 4 days, then the animals were killed and radioactivity in 17 different organs and tissues and in carcass were determined.
- Details on dosing and sampling:
- 3 females and 2 males at 1 mg/kg bw, 2 females at 113 mg/kg bw, 2 females at 1 mg/kg bw with prior administration in diet.One rat was used for monitoring radioactivity in exspired air, one rat was used for monitoring the time course of blood levels for 48 hours after administration of 1 mg/kg bw, of all remaining rats, urine and faeces were collected for 4 days, then the animals were killed and radioactivity in 17 different organs and tissues and in carcass were determined.
- Statistics:
- not reported
Results and discussion
Main ADME resultsopen allclose all
- Type:
- absorption
- Results:
- Almost no absorption after oral administration, mostly more than 90% of the dose was excreted unchanged in faeces
- Type:
- distribution
- Results:
- Almost no absorption after oral administration, mostly more than 90% of the dose was excreted unchanged in faeces
- Type:
- excretion
- Results:
- Almost no absorption after oral administration, mostly more than 90% of the dose was excreted unchanged in faeces
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- After single oral administration of 1 mg/kg bw, 83.5% of the dose was excreted in faeces by females and 92.7% of the dose by males indicating maximum absorption of 16.5% in females and 7.3% in males. After single oral administration of 113 mg/kg bw to females, 96.5% were excreted in faeces indicating maximum absorption of 3.5%. After single oral administration of 1 mg/kg bw to rats pretreated with the nonlabelled substance at 1% in diet for 14 days, 102% of the dose were excreted in faeces indicating almost no absorption.
- Details on distribution in tissues:
- The concentrations in all organs and tissues investigated, besides liver and residual carcass, were below 1 ppm. At the high dose, the liver of females contained 1.66 ppm and the residual carcass contained 1.25 ppm. All organs and tissues besides liver and residual carcass contained well below 1% of the dose. The livers of males and females at the low dose contained 1.60 and 2.29% of the dose. The residual carcass of males and females at the low dose contained 5.09 and 5.05% of the dose and of females at the high dose 0.90% of the dose. The carcass of pretreated females contained 4.44% of the dose.
- Details on excretion:
- Almost all of the administered dose was excreted unchanged in faeces. At 4 days after administration, low dose females had excreted 0.07% of the dose in urine and 83.5% in faeces, low dose males 0.01% in urine and 92.7% in faeces, high dose females 0.009% in urine and 96.5% in faeces, and pretreated low dose females 0.03% in urine and 102% n faeces. Excretion in expired air amounted to 0.004% of the administered dose within 4 days.
Toxicokinetic parametersopen allclose all
- Key result
- Test no.:
- #1
- Toxicokinetic parameters:
- Cmax: about 0.27 ppm at a dose of 1 mg/kg
- Key result
- Test no.:
- #1
- Toxicokinetic parameters:
- Tmax: about 12 hours at a dose of 1 mg/kg
Metabolite characterisation studies
- Metabolites identified:
- no
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): no bioaccumulation potential based on study results almost no absorption after oral intake
Only minimal absorption after oral administration. - Executive summary:
Dechlorane Plus as radiolabeled substance was administered once orally by gavage to a small group of male and female rats at a dose level of 1 mg/kg bw, and to small groups of female rats either at a dose level of 113 mg/kg bw or at 1 mg/kg bw preceeded by administration in the diet at 1% for 14 days as nonlabeled substance. Urine and faeces were collected for 4 days, radioactivity in exspired air was determined in one rat, and the time course of blood levels was determined in one rat over 48 hours. After 4 days, the rats were killed and radioactivity in a large range of organs and tissues and in residual carcass were determined. Only small amounts around 10% of Dechlorane Plus were absorbed after oral administration and widely distributed in the body. The highest concentration was found in the liver. About 90% of the substance was excreted unchanged in faeces. Excretion in urine and exspired air was minimal. At 4 days after administration, between 1% and 8.5% of the dose administered was found in the carcass.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.